GeneDx Holdings (WGS) Revenue Growth (1y) (2021 - 2026)
GeneDx Holdings (WGS) Revenue Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 91.39% |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 6.18% |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 3.66% |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 14.26% |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 38.82% |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 10.01% |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 8.41% |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 4.80% |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 7.17% |
| 10 | GeneDx Holdings | 2.10 Bn | 1.93 Bn | 68.21 Mn | 17.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.38% |
| Dec 31, 2025 | 26.50% |
| Sep 30, 2025 | 51.86% |
| Jun 30, 2025 | 45.63% |
| Mar 31, 2025 | 39.56% |
| Dec 31, 2024 | 66.57% |
| Sep 30, 2024 | 44.22% |
| Jun 30, 2024 | 44.77% |
| Mar 31, 2024 | 44.70% |
| Dec 31, 2023 | -6.41% |
| Sep 30, 2023 | -35.96% |
| Jun 30, 2023 | 34.66% |
| Mar 31, 2023 | -20.03% |
| Dec 31, 2022 | 6.14% |
| Sep 30, 2022 | 92.77% |
| Jun 30, 2022 | -23.07% |
| Mar 31, 2022 | -15.98% |
| Dec 31, 2021 | -9.63% |
| Sep 30, 2021 | 11.84% |
| Jun 30, 2021 | 56.19% |